Published in Healthcare Finance, Tax and Law Weekly, October 18th, 2006
The new patent also covers coating variations not specifically included in prior patents. Accelr8 previously licensed certain OptiChem applications to other companies in the biomedical industry. Accelr8 is now developing its BACcelr8r rapid bacterial diagnostic system that will use OptiChem in its single-use analytical cassette. In addition, the company plans to develop related disposable products for handling patient specimens prior to analysis.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.